Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials
Expert Opin Emerg Drugs. 2023 Dec;28(4):297-309. doi: 10.1080/14728214.2023.2293049. Epub 2023 Dec 26.ABSTRACTINTRODUCTION: Uveitis is a heterogeneous group of ocular conditions characterized by inflammation of the uveal tract. It is a leading cause of blindness in developed countries and exerts significant psychological, social, and economic impact on both patients and the larger society. While there are numerous pharmacotherapy options, posterior segment noninfectious uveitis remains a significant challenge to treat due to its severity, chronicity, and high recurrence rates.AREAS COVERED: The index review highlights the ...
Source: Expert Opinion on Emerging Drugs - December 22, 2023 Category: Drugs & Pharmacology Authors: Zheng Xian Thng Albert John Bromeo S Saeed Mohammadi Anadi Khatri Anh N T Tran Amir Akhavanrezayat Ngoc T T Than Khiem S Nguyen Woong-Sun Yoo Azadeh Mobasserian Christopher Chi Mong Or Quan Dong Nguyen Source Type: research
Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials
Expert Opin Emerg Drugs. 2023 Dec 21:1-13. doi: 10.1080/14728214.2023.2293049. Online ahead of print.ABSTRACTINTRODUCTION: Uveitis is a heterogeneous group of ocular conditions characterized by inflammation of the uveal tract. It is a leading cause of blindness in developed countries and exerts significant psychological, social, and economic impact on both patients and the larger society. While there are numerous pharmacotherapy options, posterior segment noninfectious uveitis remains a significant challenge to treat due to its severity, chronicity, and high recurrence rates.AREAS COVERED: The index review highlights the u...
Source: Expert Opinion on Emerging Drugs - December 22, 2023 Category: Drugs & Pharmacology Authors: Zheng Xian Thng Albert John Bromeo S Saeed Mohammadi Anadi Khatri Anh N T Tran Amir Akhavanrezayat Ngoc T T Than Khiem S Nguyen Woong-Sun Yoo Azadeh Mobasserian Christopher Chi Mong Or Quan Dong Nguyen Source Type: research
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?
Expert Opin Emerg Drugs. 2023 Dec 19:1-5. doi: 10.1080/14728214.2023.2296088. Online ahead of print.NO ABSTRACTPMID:38112023 | DOI:10.1080/14728214.2023.2296088 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - December 19, 2023 Category: Drugs & Pharmacology Authors: Joshua De Soyza Anita Pye Alice M Turner Source Type: research
